Refractory autoimmune haemolytic anaemia following allogenic haematopoietic stem cell transplantation: successful treatment of rituximab

OBJECTIVE: To investigate the effectiveness and safety of rituximab in treating autoimmune haemolytic anaemia (AIHA) after allogeneic haematopoietic stem cell transplantation (allo-HSCT). METHODS: Patients with refractory AIHA following allo-HSCT were treated once-weekly with rituximab 375 mg/m(2) f...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaofan, Huang, Jiafu, Zhu, Zhijuan, Li, Nainong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Pre-Clinical Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683942/
https://www.ncbi.nlm.nih.gov/pubmed/31280646
http://dx.doi.org/10.1177/0300060519855593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683942/
https://www.ncbi.nlm.nih.gov/pubmed/31280646
http://dx.doi.org/10.1177/0300060519855593

Ejemplares similares